Page last updated: 2024-10-29

ketamine and Cancer of Muscle

ketamine has been researched along with Cancer of Muscle in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bornemann-Cimenti, H1
Dorn, C1
Rumpold-Seitlinger, G1
Shimoyama, N1
Akizuki, A1
Takahashi, H1
Shimoyama, M1

Reviews

1 review available for ketamine and Cancer of Muscle

ArticleYear
[Palliative medicine for advanced gynecological malignancy].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Bone Neoplasms; Drug Therapy,

2004

Other Studies

1 other study available for ketamine and Cancer of Muscle

ArticleYear
Early Onset and Treatment of Phantom Limb Pain Following Surgical Amputation.
    Pain medicine (Malden, Mass.), 2017, 12-01, Volume: 18, Issue:12

    Topics: Aged; Amputation, Surgical; Analgesics; Anesthetics, Local; Calcitonin; Early Medical Intervention;

2017